Top Qs
Timeline
Chat
Perspective

2CBFly-NBOMe

Pharmaceutical compound From Wikipedia, the free encyclopedia

2CBFly-NBOMe
Remove ads

2CBFly-NBOMe, also known as NBOMe-2C-B-FLY or as Cimbi-31, is a serotonin receptor modulator of the phenethylamine, DOx, and FLY families. It was indirectly derived from the phenethylamine hallucinogen 2C-B is and related to benzodifurans like 2C-B-FLY and N-benzylphenethylamines like 25B-NBOMe.

Quick facts Clinical data, Other names ...
Remove ads

Interactions

Pharmacology

Pharmacodynamics

2CBFly-NBOMe acts as a potent partial agonist for the 5-HT2A serotonin receptor subtype.[1][2][3]

History

2CBFly-NBOMe was discovered in 2002,[4] and further researched by Ralf Heim at the Free University of Berlin,[5] and subsequently investigated in more detail by a team at Purdue University led by David E. Nichols.[6]

Society and culture

United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[7]

United States

2CBFly-NBOMe is a controlled substance in Vermont as of January 2016.[8]

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads